ReviewDiscover oncology2026

Translational prioritization of strategies to overcome poly ADP-ribose polymerase inhibitor resistance in breast cancer based on systematic review of preclinical evidence.

Kezhen Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.